A new report published by the the American Medical Association (AMA) finds that neither adult-use marijuana legalization nor the opening of retail stores in U.S. states...
A new federal study shows that enrollment in state-legal medical marijuana programs increased significantly across the U.S. in recent years. The researchers—from the Centers for Disease...
Single-dose psilocybin use is “not associated with risk of paranoia,” while other adverse effects such as headaches are generally “tolerable and resolved within 48 hours”—according to...
A recently published analysis of smokable hemp products by researchers at the National Institute of Standards and Technology (NIST) found that the vast majority of samples–about...
A new scientific review highlights the potential of CBD to treat and manage the symptoms of conditions like epilepsy, pain, cancer, schizophrenia, diabetes and COVID-19, among...
Newly released data from a Washington State survey of adolescent and teenage students show declines in both lifetime and past-30-day marijuana use in recent years, with...
A new study funded by the National Institute on Drug Abuse (NIDA) has found that a citrusy-smelling terpene in marijuana could help ease anxiety and paranoia...
“Approximately 70 percent of the labels reported THC percentages more than 15 percent higher than what was quantified through the lab.” By Anna Schwabe, University of...
A new review of scientific literature around CBD and its effects suggests that the cannabinoid could be useful in managing symptoms of alcohol use disorder (AUD)...
The U.S. Department of Agriculture (USDA) says a genetically modified version of hemp produced by researchers in Wisconsin “may be safely grown and bred in the...